Medicap Healthcare Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹0(0.00%)
Premium (ELP)
Medicap Healthcare Limited's is preparing to launch its Initial Public Offering (IPO) with a substantial issue size of TBD. The offering comprises a fresh issue component of TBD.
The price band for the IPO has been set at TBD, providing investors with a range to place their bids. The minimum investment lot consists of TBD, making it accessible to both retail and institutional investors.
The subscription window for this public offering opens on TBD and will conclude on TBD. Following the subscription period, the share allotment is scheduled for TBD, with the official listing expected to commence on TBD on the NSE, BSE exchange.
Medicap Healthcare Limited, founded on 2 June 2017, specializes in pharmaceutical packaging, focusing on products like Euro Head caps, bottle preforms, Blood Collection Tubes, and components for Water for Injection supply. The company serves the pharma and healthcare sectors from a 6,732 sq ft modern manufacturing facility equipped with advanced technology. As of August 31, 2025, it employed 66 permanent staff and offers products including Euro Head Caps, Bottle Preforms, and other items such as plastic and protector caps
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
The expected premium is based on market buzz and online information. It should not be considered as the actual listing price or valuation. Always refer to the RHP and seek advice from a financial expert before making any investment decisions.
- Established Healthcare Presence: Operates in the pharmaceutical and healthcare sector, supplying medicines and related products to hospitals, clinics, and pharmacies.
- Diverse Product Portfolio: Offers a range of pharmaceutical formulations, catering to multiple therapeutic segments, which helps reduce dependency on any single product.
- Growth Potential in Healthcare Market: Rising demand for healthcare products and services supports long-term scalability and expansion opportunities.
- Regulatory Compliance Risk: Being in the pharmaceutical sector, the company is subject to strict regulations, and any non-compliance could affect operations.
- High Working Capital Needs: Procurement, inventory, and distribution of pharmaceutical products require significant investment, impacting cash flow.
- Competitive Industry: Faces competition from both organized and unorganized players in the pharmaceutical sector, which can pressure pricing and margins
- Kamalkumar Aggarwal
- Rajveer Kamal Aggarwal
- Minal Aggarwal
Medicap Healthcare Limited
Kfin Technologies Limited